Practice
Featured experience
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Durational Capital Management strategic investment in Garage Beer
We are advising Durational Capital Management on the transaction
Arcos Dorados renewal of long-term master franchise agreement with McDonald’s
We advised Arcos Dorados on the transaction
GSK strategic alliance with Vesalius Therapeutics
We advised GSK on the transaction
Davis Polk Advises Roche on Its Acquisition of Promedior
Davis Polk is advising Roche on its acquisition of Promedior, Inc. Under the terms of the merger agreement, Roche will make…
Davis Polk Advises Centogene N.V. on Its Initial Public Offering
Davis Polk advised Centogene N.V. on its $56 million initial public offering of 4,000,000 of its common shares. In addition,…
Advice to Whitney Wolfe Herd on Blackstone majority investment in MagicLab
Davis Polk is advising Whitney Wolfe Herd, the founder and CEO of Bumble, in connection with the acquisition by Blackstone…
RAPT Therapeutics, Inc. Initial Public Offering
Davis Polk advised the underwriters in connection with a $38.4 million initial public offering of common stock of RAPT…
Davis Polk Advises Hudson Group on Its Acquisition of a Controlling Stake in the Assets of OHM Concession Group
Davis Polk is advising Hudson Group in connection with its acquisition of a controlling stake in the assets of OHM…
Murray Energy chapter 11 restructuring and DIP financing
Davis Polk is advising an ad hoc group (the “Ad Hoc Group”) of prepetition superpriority secured lenders and post-petition…
Progyny $149.5 Million Initial Public Offering and Nasdaq Listing
Davis Polk advised the underwriters on the SEC-registered initial public offering by Progyny, Inc. of 11,500,000 common…
Davis Polk Advises Youdao, Inc. on Its Initial Public Offering, NYSE Listing and Concurrent Private Placements
Davis Polk advised Youdao, Inc. on its SEC-registered initial public offering of 5,600,000 American Depositary Shares. Each…
Innate Pharma $79 Million U.S. Initial Public Offering of ADS on Nasdaq and Concurrent Private Placement
Davis Polk advised the underwriters in connection with an initial public offering of 8,047,227 American Depositary Shares of…
BioNTech SE Initial Public Offering on Nasdaq
Davis Polk advised the underwriters in connection with the $150 million initial public offering of 10,000,000 American…